Actively Recruiting
Electrical Phrenic Nerve Stimulation in Patients With VIDD
Led by Peking University Third Hospital · Updated on 2024-11-12
40
Participants Needed
1
Research Sites
82 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study aims to examine efficacy of transcutaneous electrical phrenic nerve stimulation (TEPNS) in ventilator-induced diaphragmatic dysfunction (VIDD). The investigators recruit VIDD patients, and randomly assign the patients into TEPNS group and control group. TEPNS group receives TEPNS twice a day for consecutive 5 days. Control group only receives usual care. The investigators collect diaphragm function indicators and outcomes to evaluate the efficacy.
CONDITIONS
Official Title
Electrical Phrenic Nerve Stimulation in Patients With VIDD
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Aged 18 years or older
- Ventilated for at least 48 hours with an expected ICU stay of more than 7 days
- Diaphragm thickening fraction less than 25%
You will not qualify if you...
- Having a pacemaker
- Skin lesions that could interfere with electrode probes
- Previous diaphragmatic nerve paralysis
- Body mass index over 35 kg/m2
- Severe chronic obstructive pulmonary disease (FEV1/FVC less than 30%)
- Pregnancy or breastfeeding
- Decision to withhold life-sustaining treatment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Peking University Third Hospital
Beijing, Beijing Municipality, China, 100191
Actively Recruiting
Research Team
Z
Zongyu Wang, Dr.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here